The majority of children and adolescents with acute myeloid leukemia have detectable anti-DT388-GMCSF IgG concentrations, but at concentrations that should not preclude in vivo activity

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 7, 2002, Pages 521-526

  Hall, Philip D ^a   Razzouk, Bassem I ^b   Willoughby, Tony E ^a   McLean, Thomas W ^c   Frankel, Arthur E ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c WAKE FOREST UNIVERSITY   (United States)

Author keywords

Acute myeloid leukemia; Diphtheria fusion toxin; Human GM CSF

Indexed keywords

AUTOANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INFANT; MALE; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIPHTHERIA TOXIN; DIPHTHERIA TOXOID; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HL-60 CELLS; HUMAN; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGE; RECOMBINANT FUSION PROTEINS; SUPPORT, NON-U.S. GOV'T; VACCINATION;

EID: 0242516121     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200210000-00005     Document Type: Article

References (17)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Weinstein HJ, Tarbell NJ. Leukemias and lymphomas in childhood. In: DeVita VT, Hellman S, Rosenberg SA. Cancer Principles & Practice of Oncology, 5th Ed. Philadelphia: Lippincott-Raven, 1997:2145-65.
3. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 1996;334:1428-34.
4. Wells RJ, Woods WG, Buckley JD, et al. Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Children's Cancer Group study. J Clin Oncol 1994;12:2367-77.
5. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 1993;11:1046-54.
6. Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group. Blood 1996;87:4979-89.
7. Hogge DE, Willman CL, Kreitman RJ, et al. Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxingranulocyte-macrophage colony stimulating factor fusion protein. Blood 1998;92:589-95.
8. Thrush GR, Lark LR, Clinchy BC, et al. Immunotoxins: An update. Ann Rev Immunol 1996;14:49-71.
9. 388-GM-CSF, a novel fusion toxin consisting of a truncated diphtheria toxin fused to human granulocytemacrophage colony-stimulating factor, prolongs survival in a SCID mouse model of acute myeloid leukemia. Leukemia 1999;13:629-33.
10. Hotchkiss CE, Hall PD, Cline JM, et al. Toxicology and pharmacokinetics of a truncated diphtheria toxin (DT388) linked to human granulocyte-macrophage colony stimulating factor (GM-CSF) in cynomolgus monkeys. Toxic Appl Pharm 1999;158:152-60.
11. 388-GMCSF) for refractory or relapsed acute myeloid leukemia (AML). Clin Cancer Res (in press).
12. Kraisinger M. Update on childhood immunization. Am J Health Syst Pharm 1998;55:563-9.
13. Hall PD, Virella G, Willoughby T, et al. Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia. Clin Immunol 2001;100:191-7.
14. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: A report from the Children's Cancer Group. Blood 2001;9756-62.
15. List AF. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 1996;10:937-42.
16. Frankel AE, Hall PD, Burbage C, et al. Modulation of the apoptotic response of human myeloid leukemia cells to a diphtheria toxin granulocyte-macrophage colony stimulating factor fusion protein. Blood 1997;90:3654-61.
17. Frankel AE, McCubrey JA, Miller MS, et al. Diphtheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias. Leukemia 2000;14:576-85.